Cargando…
Human immunodeficiency virus & cardiovascular risk
Highly active antiretroviral therapy (HAART) significantly changed the prevalence of the cardiovascular manifestations of human immunodeficiency virus (HIV)/AIDS. In developed countries, a 30 per cent reduction in the prevalence of cardiomyopathy and pericardial effusion was observed, possibly relat...
Autores principales: | Barbaro, Giuseppe, Barbarini, Giorgio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3284097/ https://www.ncbi.nlm.nih.gov/pubmed/22310821 http://dx.doi.org/10.4103/0971-5916.92634 |
Ejemplares similares
-
Human immunodeficiency virus infection and cardiovascular risk
por: Zaharia-Kézdi, Erzsébet Iringó, et al.
Publicado: (2014) -
Influence of immune activation and inflammatory response on cardiovascular risk associated with the human immunodeficiency virus
por: Beltrán, Luis M, et al.
Publicado: (2015) -
Review of cardiovascular magnetic resonance in human immunodeficiency virus-associated cardiovascular disease
por: Sood, Vishesh, et al.
Publicado: (2017) -
Atazanavir and Cardiovascular Risk Among Human Immunodeficiency Virus-Infected Patients: A Systematic Review
por: Chow, Dominic, et al.
Publicado: (2016) -
Assessment of Cardiovascular Risk and Arterial Stiffness in Patients With Human Immunodeficiency Virus
por: Freitas, Mariana, et al.
Publicado: (2023)